| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |